Insights & Publications

Pharmaceuticals & Medical Products

article

Rapid growth in biopharma: Challenges and opportunities

December 2014—Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations.more

Editor's choice

A-digital-prescription_1536x1536_Thumbnail
article

A digital prescription for pharma companies

November 2014—Pharmaceutical and medical-device companies have been slow to adopt digitization. Here are five reasons they should get moving. more

Pharma_1536x1536_Thumbnail
article | McKinsey Quarterly

Confronting change fatigue in the pharmaceutical industry

September 2014—A decade of restructuring and transformation efforts has taken a toll on organizational health.more

Horwood_1536x1536_Thumbnail
commentary

Developing a global digital strategy

October 2014—How does a global company take advantage of digital technology? Johnson & Johnson’s vice president of digital strategy, Gail Horwood, explains.more

  • includes:
    •  
Pharma_launches_1536x1536_Thumbnail
article

Pharma’s first-to-market advantage

September 2014—What’s the value of bringing a drug to market first? In some cases, it may be less than you think.more

Healthcares-digital-future_1536x1536_Thumbnail
article

Healthcare’s digital future

July 2014—Insights from our international survey can help healthcare organizations plan their next moves in the journey toward full digitization.more

Donaldson_1536x1536_Thumbnail
interview

Designing for social impact: The D-Rev story

June 2014—Many companies target the world’s emerging middle-class consumers. Fewer mirror nonprofit D-Rev, which aims to improve the health and lives of people living on less than $4 a day.more

  • includes:
    •  
Pharma-launches_1536x1536_Thumbnail
article

The secret of successful drug launches

March 2014—About two-thirds of drug launches don’t meet expectations. Improving that record requires pharmaceutical companies to recognize the world has changed and adjust their marketing accordingly.more

Pharma-mergers_1536x1536_Thumbnail
article

Why pharma megamergers work

February 2014—Unlike deals in many industries, big mergers and acquisitions among pharmaceutical companies generally have resulted in positive returns to shareholders.more

About this content

The material on this page draws on the research and experience of McKinsey consultants and other sources. To learn more about our expertise, please visit the Pharmaceuticals & Medical Products Practice.